GILLETTEGillette India Limited
FMCG · Household & Personal Products · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Gillette India Limited engages in the manufacture and sale of grooming and oral care products in India and internationally. It offers shaving system and cartridges, blades, toiletries, razors, and other components. The company also offers toothbrushes and oral care products. In addition, the company provides body shaving and trimming; skin care; and shaving gel, shaving cream & after shave; and female grooming products under the Venus brand name. The company sells its products primarily under the GilletteLabs, SkinGuard Sensitive, Fusion5, MACH3, Disposable Razor, Guard3, and Styler brand names. Gillette India Limited markets and sells its products through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, and high frequency stores. The company was incorporated in 1984 and is based in Mumbai, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on GILLETTE — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Profit growth: 21.3% YoY
- • ROE: 66.4%
- • ROCE: 58.0%
- • MACD: bullish
- • Volatility: 23% annualized
- • Liquidity: ₹11.5 cr avg turnover
Bull case
- • Profit growth: 21.3% YoY
- • ROE: 66.4%
- • ROCE: 58.0%
- • MACD: bullish
Bear case
- • Revenue growth: 3.2% YoY
- • Valuation vs sector: P/E 44.7 vs sector 24.6
- • RSI: 39
- • Price vs EMA21: below
Key risks
- • Momentum is fading versus the broader market
- • Revenue growth: 3.2% YoY
- • Valuation vs sector: P/E 44.7 vs sector 24.6
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹121.51). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.